NGM BIOPHARMACEUTICALS INC Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.49 | 2,416 | 30,176 | 1,038,170 | 1 M to 1 M (+0.23 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.22 | 128,377 | 1,568,767 | 1,035,754 | 907.4 K to 1 M (+14.15 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.63 | 170,387 | 1,981,601 | 907,377 | 737 K to 907.4 K (+23.12 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,205,077 | 17.2 M to 17.2 M (+0.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,202,661 | 17.1 M to 17.2 M (+0.75 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,074,284 | 16.9 M to 17.1 M (+1.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,395,077 | 17.4 M to 17.4 M (+0.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,392,661 | 17.3 M to 17.4 M (+0.74 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,205,077 | 17.2 M to 17.2 M (+0.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,264,284 | 17.1 M to 17.3 M (+1.00 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,202,661 | 17.1 M to 17.2 M (+0.75 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,074,284 | 16.9 M to 17.1 M (+1.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.49 | 2,416 | 30,176 | 1,038,170 | 1 M to 1 M (+0.23 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.22 | 128,377 | 1,568,767 | 1,035,754 | 907.4 K to 1 M (+14.15 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.63 | 170,387 | 1,981,601 | 907,377 | 737 K to 907.4 K (+23.12 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,395,077 | 17.4 M to 17.4 M (+0.01 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,392,661 | 17.3 M to 17.4 M (+0.74 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,264,284 | 17.1 M to 17.3 M (+1.00 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.49 | 2,416 | 30,176 | 1,038,170 | 1 M to 1 M (+0.23 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.22 | 128,377 | 1,568,767 | 1,035,754 | 907.4 K to 1 M (+14.15 %) |
| Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.63 | 170,387 | 1,981,601 | 907,377 | 737 K to 907.4 K (+23.12 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.77 | 143,082 | 1,684,075 | 16,903,897 | 16.8 M to 16.9 M (+0.85 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.59 | 148,464 | 1,720,698 | 16,760,815 | 16.6 M to 16.8 M (+0.89 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.77 | 143,082 | 1,684,075 | 17,093,897 | 17 M to 17.1 M (+0.84 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.59 | 148,464 | 1,720,698 | 16,950,815 | 16.8 M to 17 M (+0.88 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.77 | 143,082 | 1,684,075 | 736,990 | 593.9 K to 737 K (+24.09 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.59 | 148,464 | 1,720,698 | 593,908 | 445.4 K to 593.9 K (+33.33 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.77 | 143,082 | 1,684,075 | 736,990 | 593.9 K to 737 K (+24.09 %) |
| Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.59 | 148,464 | 1,720,698 | 593,908 | 445.4 K to 593.9 K (+33.33 %) |
| Mar 06 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 18.00 | 8,307 | 149,526 | 445,444 | 437.1 K to 445.4 K (+1.90 %) |
| Mar 06 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 18.00 | 8,307 | 149,526 | 445,444 | 437.1 K to 445.4 K (+1.90 %) |
| Mar 06 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 18.00 | 8,307 | 149,526 | 16,612,351 | 16.6 M to 16.6 M (+0.05 %) |
| Mar 06 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 18.00 | 8,307 | 149,526 | 16,802,351 | 16.8 M to 16.8 M (+0.05 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.96 | 9,986 | 179,349 | 437,137 | 427.2 K to 437.1 K (+2.34 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.99 | 38,758 | 697,256 | 427,151 | 388.4 K to 427.2 K (+9.98 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.90 | 14,124 | 252,820 | 388,393 | 374.3 K to 388.4 K (+3.77 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.96 | 9,986 | 179,349 | 437,137 | 427.2 K to 437.1 K (+2.34 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.99 | 38,758 | 697,256 | 427,151 | 388.4 K to 427.2 K (+9.98 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.90 | 14,124 | 252,820 | 388,393 | 374.3 K to 388.4 K (+3.77 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.96 | 9,986 | 179,349 | 16,604,044 | 16.6 M to 16.6 M (+0.06 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.99 | 38,758 | 697,256 | 16,594,058 | 16.6 M to 16.6 M (+0.23 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.90 | 14,124 | 252,820 | 16,555,300 | 16.5 M to 16.6 M (+0.09 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.96 | 9,986 | 179,349 | 16,794,044 | 16.8 M to 16.8 M (+0.06 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.99 | 38,758 | 697,256 | 16,784,058 | 16.7 M to 16.8 M (+0.23 %) |
| Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.90 | 14,124 | 252,820 | 16,745,300 | 16.7 M to 16.7 M (+0.08 %) |